跳至主要内容
临床试验/CTRI/2023/01/049024
CTRI/2023/01/049024尚未招募未知

Study of efficacy and patient satisfaction with subcutaneous vs intramuscular testosterone enanthate in hypogonadal male patients

Dr Nikhil Bhagwat0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Adult hypogonadal men >=18 who are already on stable dose of Intramuscular Testosterone Enanthate therapy for more than 3 months duration

排除标准

  • 1.Coexistent Liver /Renal dysfunction
  • 2.Congestive heart failure
  • 3.History of following within the last 6 months of screening: Myocardial infarction (MI), unstable angina leading to hospitalization, percutaneous coronary intervention, coronary artery bypass graft, uncontrolled cardiac arrhythmia, stroke transient ischemia attack, carotid revascularization, endovascular procedure, or surgical intervention for peripheral vascular disease
  • 4.Systemic infections
  • 5.Positive serology for HIV, hepatitis B or hepatitis C
  • 6.Skin conditions in injection site that could confound injection site assessments.
  • 7.Use of other androgens (DHEA), anabolic steroids, other sex hormones) or other substances/supplements
  • 8.History or current evidence of breast or prostate cancer
  • 9.Elevated prostate-specific antigen (PSA) for age
  • 10.H/o psychiatric illnesses

研究者

发起方
Dr Nikhil Bhagwat

相似试验